期刊
CHEMICAL & PHARMACEUTICAL BULLETIN
卷 62, 期 4, 页码 354-363出版社
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/cpb.c13-00961
关键词
diisobutylaluminum hydride; ring-expansion rearrangement; cyclic oxime; urate transporter-1 (URAT-1) inhibitor; arginine vasopressin (AVP) antagonist; 17 beta-hydroxysteroid dehydrogenase type-3 (17 beta-HSD3) inhibitor
资金
- KAKENHI [23590001]
- Cabinet Office, Government of Japan
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- JSPS
- Japan Tobacco Inc.
- Banyu Life Science Foundation International
- Grants-in-Aid for Scientific Research [26253001, 23590001] Funding Source: KAKEN
Synthesis of three clinical candidates for medicines, a human urate transporter-1 inhibitor, an arginine vasopressin antagonist, and a 17 beta-hydroxysteroid dehydrogenase type-3 inhibitor, is described. These compounds were synthesized via construction of their 3,4-dihydro-2H-benzo[b][1,4]oxazine, dibenzodiazepine, and dibenzazocine skeletons, respectively, using the reductive ring-expansion reaction of the corresponding bicyclic or tricyclic oximes with diisobutylaluminum hydride.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据